Frontlight ResearchEarly access
Trial site
CHU Bordeaux Haut-Leveque
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Asthma2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Ulcerative colitis2 trials
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Congenital heart disease1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Lung cancer1 trial
- Obesity1 trial
- Pancreatic cancer1 trial
- Peripheral artery disease1 trial
- and 2 more
- Phase
- Phase 35 trials
- Phase 24 trials
- Phase 41 trial
- Status
- Recruiting6 trials
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Institut du Cancer de Montpellier - Val d'Aurelle1 trial
- University Hospital, Montpellier1 trial
- University Hospital, Rouen1 trial
- University Hospital, Toulouse1 trial
Running trials
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma2 recruiting
- Colorectal cancer1 recruiting
- Congenital heart disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Lung cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026